These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 2174314)

  • 1. Pilot Study of sC5b-9 and Bb Fragment Plasma Levels in Crescentic Immunoglobulin A Nephropathy.
    Guzzo G; Sadallah S; Rousson V; Herrera-Gómez F; Pantaleo G; Pascual M; Teta D
    Kidney Int Rep; 2024 May; 9(5):1517-1520. PubMed ID: 38707793
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of final complement components after kidney transplantation as a marker of delayed graft function severity.
    Arias-Cabrales CE; Riera M; Pérez-Sáez MJ; Gimeno J; Benito D; Redondo D; Burballa C; Crespo M; Pascual J; Rodríguez E
    Clin Kidney J; 2021 Apr; 14(4):1190-1196. PubMed ID: 33841865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?
    Mastellos DC; Reis ES; Biglarnia AR; Waldman M; Quigg RJ; Huber-Lang M; Seelen MA; Daha MR; Lambris JD
    Clin Immunol; 2019 Jan; 198():102-105. PubMed ID: 30472267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Complement System in Dialysis: A Forgotten Story?
    Poppelaars F; Faria B; Gaya da Costa M; Franssen CFM; van Son WJ; Berger SP; Daha MR; Seelen MA
    Front Immunol; 2018; 9():71. PubMed ID: 29422906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.
    DeAngelis RA; Reis ES; Ricklin D; Lambris JD
    Immunobiology; 2012 Nov; 217(11):1097-105. PubMed ID: 22964235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation by cellulosic dialysis membranes.
    Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
    J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples.
    Kolb WP; Morrow PR; Tamerius JD
    Complement Inflamm; 1989; 6(3):175-204. PubMed ID: 2472921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
    Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
    Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP; Ruddy S; Schwartz LB; Moxley G
    Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI; McLeod E; Devine DV
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
    Hauser AC; Derfler K; Stockenhuber F; Janata O; Balcke P
    Clin Sci (Lond); 1990 Nov; 79(5):471-6. PubMed ID: 2174314
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.